Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ESC 2014 Shines Spotlight On The Future Of Cardiology

Executive Summary

The cardiology sector, long known as one of the most innovative in medtech, has a new wave of technologies on the horizon that could help reinvigorate the sector and create new multibillion-dollar market opportunities for device manufacturers. We take a closer look at these technologies, which include vagal nerve stimulation, remote monitoring for heart failure, as well as innovation in the percutaneous coronary intervention space, all of which were all in the spotlight at the recent European Society of Cardiology Congress 2014 in Barcelona.

You may also be interested in...



VitalConnect’s Wearable Helps Predict Heart Failure Hospitalization In LINK HF

Results of the LINK HF study showed PhysIQ’s machine learning system and VitalConnect’s wearable monitor can accurately predict impending heart failure hospitalizations.

Digital Health Pushing Telemedicine To Center Stage

Remote monitoring is proving to be the driving force in the industry’s quest to reduce costs by keeping patients out of hospitals, and telemedicine is positioned to become a major part of that scheme. However, telemedicine has a number of components and players, and while the market offers opportunities, it could also prove to be somewhat disruptive to companies and products that do not fit in the envisioned landscape.

Boston Sci Links With Guidewire Specialist In Pursuit Of 2015 FFR Launch

Boston Scientific signed an agreement with the Japanese guidewire-maker Asahi Intecc to develop a fractional flow reserve wire that Boston seeks to launch as part of its first FFR system next year. Asahi will also provide components to upgrade Boston’s RotaWire atherectomy guidewire.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035825

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel